Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 915
Gene Symbol: CD3D
CD3D 		0.300 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008
Entrez Id: 10537
Gene Symbol: UBD
UBD 		0.300 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008
Entrez Id: 1003
Gene Symbol: CDH5
CDH5 		0.300 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008
Entrez Id: 3484
Gene Symbol: IGFBP1
IGFBP1 		0.300 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008
Entrez Id: 6522
Gene Symbol: SLC4A2
SLC4A2 		0.300 Biomarker disease CTD_human Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells. 18188457 2008
Entrez Id: 10412
Gene Symbol: NSA2
NSA2 		0.300 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008
Entrez Id: 123264
Gene Symbol: SLC51B
SLC51B 		0.300 Biomarker disease CTD_human Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. 16423920 2006
Entrez Id: 200931
Gene Symbol: SLC51A
SLC51A 		0.300 Biomarker disease CTD_human Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. 16423920 2006
Entrez Id: 4015
Gene Symbol: LOX
LOX 		0.300 Biomarker disease CTD_human Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2. 16023247 2005
Entrez Id: 4017
Gene Symbol: LOXL2
LOXL2 		0.300 Biomarker disease CTD_human Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2. 16023247 2005
Entrez Id: 9429
Gene Symbol: ABCG2
ABCG2 		0.300 Biomarker disease CTD_human Influence of biliary cirrhosis on the detoxification and elimination of a food derived carcinogen. 15542527 2004
Entrez Id: 6352
Gene Symbol: CCL5
CCL5 		0.300 Biomarker disease CTD_human Fibrates suppress chenodeoxycholic acid-induced RANTES expression through inhibition of NF-kappaB activation. 12126966 2002
Entrez Id: 3594
Gene Symbol: IL12RB1
IL12RB1 		0.300 Biomarker disease HPO
Entrez Id: 64506
Gene Symbol: CPEB1
CPEB1 		0.200 Biomarker disease RGD Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease. 26627607 2016
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA 		0.200 Biomarker disease RGD Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease. 26627607 2016
Entrez Id: 3717
Gene Symbol: JAK2
JAK2 		0.200 Therapeutic disease RGD Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis. 24619965 2014
Entrez Id: 57817
Gene Symbol: HAMP
HAMP 		0.200 Therapeutic disease RGD Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation. 23704825 2013
Entrez Id: 5972
Gene Symbol: REN
REN 		0.200 Biomarker disease RGD Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. 22266601 2012
Entrez Id: 361
Gene Symbol: AQP4
AQP4 		0.200 Biomarker disease RGD Role of aquaporin-4 in the development of brain oedema in liver failure. 20451280 2010
Entrez Id: 4313
Gene Symbol: MMP2
MMP2 		0.200 Therapeutic disease RGD Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. 20056896 2010
Entrez Id: 4322
Gene Symbol: MMP13
MMP13 		0.200 Therapeutic disease RGD Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. 20056896 2010
Entrez Id: 4314
Gene Symbol: MMP3
MMP3 		0.200 Therapeutic disease RGD Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. 20056896 2010
Entrez Id: 3565
Gene Symbol: IL4
IL4 		0.200 Therapeutic disease RGD The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis. 20442198 2010
Entrez Id: 1277
Gene Symbol: COL1A1
COL1A1 		0.200 Therapeutic disease RGD Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. 20056896 2010
Entrez Id: 4318
Gene Symbol: MMP9
MMP9 		0.200 Therapeutic disease RGD Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. 20056896 2010